The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

AI Enters the Clinician Scope-of-Practice Turf Wars

Clinical workforce debates have long turned on one question: who should provide care, at what level of independence, and accountable to whom? For years, physicians and advanced practice providers have fought over those lines through scope-of-practice legislation, title disputes, and collective bargaining. According to Becker's Hospital Review, AI is now adding a new layer of tension to those negotiations.

The practical issue is that AI tools increasingly perform tasks once reserved for licensed clinicians, from drafting notes to flagging diagnoses and suggesting treatment steps. That blurs traditional boundaries. If an algorithm recommends a course of action, it is unclear who carries responsibility when something goes wrong: the physician, the advanced practice provider operating with more independence, or the health system that deployed the tool.

For hospital leaders, the takeaway is that AI is not a neutral efficiency play. It reshapes accountability and supervision structures that scope-of-practice rules were built to govern. Expect AI to become a recurring flashpoint in licensing fights, staffing models, and liability discussions across the clinical workforce.

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.